Dosimetric quality endpoints for low-dose-rate prostate brachytherapy using biological effective dose (bed) vs. conventional dose

By Singh R.   Al-Hallaq H.   Pelizzari C.A.   Zagaja G.P.   Chen A.   Jani A.B.  

Medical Dosimetry, Vol. 28, Iss. 4, 2003-12 ,pp. : 255-259

Elsevier

Access to resources Recommend Favorite

Acute Side Effects after Dose-Escalation Treatment of Prostate Cancer Using the New Urethral Catheter BeamCath^® Technique

By Fransson Per   Löfroth Per-Olov   Franzén Lars   Henriksson Roger   Bergström Per   Widmark Anders  

Acta Oncologica, Vol. 40, Iss. 6, 2001-11 ,pp. : 756-765

Informa Healthcare

Access to resources Recommend Favorite

Prostatic sarcoma after conservative treatment with brachytherapy for low-risk prostate cancer

By Domínguez Arturo  

Acta Oncologica, Vol. 52, Iss. 6, 2013-08 ,pp. : 1215-1216

Informa Healthcare

Access to resources Recommend Favorite

Small cell carcinoma of the prostate after high-dose-rate brachytherapy for low-risk prostatic adenocarcinoma

By            

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 53-56

Spandidos Publications

Access to resources Recommend Favorite

Quality Assessment of Interstitial Implants in High- Dose- Rate Brachytherapy After Lumpectomy in Patients of Early Stage Breast Cancer

By Dutta Samrat  

Indian Journal of Surgical Oncology, Vol. 1, Iss. 4, 2010-12 ,pp. : 294-302

Springer Publishing Company

Access to resources Recommend Favorite